Healthcare >> CEO Interviews >> October 23, 2015
Amit Munshi is President and Chief Executive Officer of EPIRUS Biopharmaceuticals, Inc. Mr. Munshi is the former CEO of Percivia LLC, and also was a Co-Founder and the Chief Business Officer at Kythera Biopharmaceuticals (NASDAQ:KYTH). Previously, he held leadership positions at Amgen (NASDAQ:AMGN), including General Manager of European Nephrology. Mr. Munshi has more than 24 years of pharmaceutical and biotechnology experience both in the U.S. and internationally, including general management, product development, licensing and business development. Profile
TWST: Briefly provide an overview of the company and an explanation of the business model if it is unique.
Mr. Munshi: We are a pure-play biosimilar company that is focused on building